Literature DB >> 30936027

Management of epithelial cancer of the ovary, fallopian tube, and primary peritoneum. Long text of the Joint French Clinical Practice Guidelines issued by FRANCOGYN, CNGOF, SFOG, and GINECO-ARCAGY, and endorsed by INCa. Part 1: Diagnostic exploration and staging, surgery, perioperative care, and pathology.

V Lavoue1, C Huchon2, C Akladios3, P Alfonsi4, N Bakrin5, M Ballester6, S Bendifallah7, P A Bolze8, F Bonnet9, C Bourgin10, N Chabbert-Buffet7, P Collinet10, B Courbiere11, T De la Motte Rouge12, M Devouassoux-Shisheboran13, C Falandry14, G Ferron15, L Fournier16, L Gladieff17, F Golfier8, S Gouy18, F Guyon19, E Lambaudie20, A Leary21, F Lecuru22, M A Lefrere-Belda23, E Leblanc24, A Lemoine9, F Narducci24, L Ouldamer25, P Pautier21, F Planchamp26, N Pouget27, I Ray-Coquard28, C Rousset-Jablonski28, C Senechal-Davin19, C Touboul29, I Thomassin-Naggara30, C Uzan31, B You32, E Daraï7.   

Abstract

An MRI is recommended for an ovarian mass that is indeterminate on ultrasound. The ROMA score (combining CA125 and HE4) can also be calculated (grade A). In presumed early-stage ovarian or tubal cancers, the following procedures should be performed: an omentectomy (at a minimum, infracolic), an appendectomy, multiple peritoneal biopsies, peritoneal cytology (grade C), and pelvic and para-aortic lymphadenectomies (grade B) for all histologic types, except the expansile mucinous subtypes, for which lymphadenectomies can be omitted (grade C). Minimally invasive surgery is recommended for early-stage ovarian cancer, when there is no risk of tumor rupture (grade B). For FIGO stages III or IV ovarian, tubal, and primary peritoneal cancers, a contrast-enhanced computed tomography (CT) scan of the thorax/abdomen/pelvis is recommended (grade B), as well as laparoscopic exploration to take multiple biopsies (grade A) and a carcinomatosis score (Fagotti score at a minimum) (grade C) to assess the possibility of complete surgery (i.e., leaving no macroscopic tumor residue). Complete surgery by a midline laparotomy is recommended for advanced ovarian, tubal, or primary peritoneal cancer (grade B). For advanced cancers, para-aortic and pelvic lymphadenectomies are recommended when metastatic adenopathy is clinically or radiologically suspected (grade B). When adenopathy is not suspected and when complete peritoneal surgery is performed as the initial surgery for advanced cancer, the lymphadenectomies can be omitted because they do not modify either the medical treatment or overall survival (grade B). Primary surgery (before other treatment) is recommended whenever it appears possible to leave no tumor residue (grade B).
Copyright © 2019 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Chemotherapy; Guidelines; Ovarian cancer; Primary peritoneal cancer; Surgery; Tubal cancer

Mesh:

Substances:

Year:  2019        PMID: 30936027     DOI: 10.1016/j.jogoh.2019.03.017

Source DB:  PubMed          Journal:  J Gynecol Obstet Hum Reprod        ISSN: 2468-7847


  6 in total

Review 1.  The Anterior GRadient (AGR) family proteins in epithelial ovarian cancer.

Authors:  Delphine Fessart; Jacques Robert; Cecile Hartog; Eric Chevet; Frederic Delom; Guillaume Babin
Journal:  J Exp Clin Cancer Res       Date:  2021-08-27

2.  Onco-gynecologic surgery in the COVID-19 era: Risks and precautions-A position paper from FRANCOGYN, SCGP, SFCO, and SFOG.

Authors:  Vincent Lavoué; Cherif Akladios; Laurence Gladieff; Jean-Marc Classe; Fabrice Lécuru; Pierre Collinet
Journal:  J Gynecol Obstet Hum Reprod       Date:  2020-05-11

3.  Real-World Data on Newly Diagnosed BRCA-Mutated High-Grade Epithelial Ovarian Cancers: The French National Multicenter ESME Database.

Authors:  Marta Bini; Stanislas Quesada; Pierre Meeus; Manuel Rodrigues; Eric Leblanc; Anne Floquet; Patricia Pautier; Frédéric Marchal; Magali Provansal; Loïc Campion; Sylvain Causeret; Sophie Gourgou; Isabelle Ray-Coquard; Jean-Marc Classe; Christophe Pomel; Thibault De La Motte Rouge; Emmanuel Barranger; Aude Marie Savoye; Cécile Guillemet; Laurence Gladieff; Martin Demarchi; Roman Rouzier; C Courtinard; Clémence Romeo; Florence Joly
Journal:  Cancers (Basel)       Date:  2022-08-21       Impact factor: 6.575

4.  Management and Survival of Elderly and Very Elderly Patients with Ovarian Cancer: An Age-Stratified Study of 1123 Women from the FRANCOGYN Group.

Authors:  Yolaine Joueidi; Ludivine Dion; Sofiane Bendifallah; Camille Mimoun; Alexandre Bricou; Krystel Nyangoh Timoh; Pierre Collinet; Cyril Touboul; Lobna Ouldamer; Henri Azaïs; Yohann Dabi; Cherif Akladios; Geoffroy Canlorbe; Pierre-Adrien Bolze; Hélène Costaz; Mathieu Mezzadri; Tristan Gauthier; Frederic Kridelka; Pauline Chauvet; Nicolas Bourdel; Martin Koskas; Xavier Carcopino; Emilie Raimond; Olivier Graesslin; Lise Lecointre; Marcos Ballester; Cyrille Huchon; Jean Levêque; Vincent Lavoué
Journal:  J Clin Med       Date:  2020-05-13       Impact factor: 4.241

5.  Increased Diagnostic Accuracy of Adnexal Tumors with A Combination of Established Algorithms and Biomarkers.

Authors:  Maria Lycke; Benjamin Ulfenborg; Björg Kristjansdottir; Karin Sundfeldt
Journal:  J Clin Med       Date:  2020-01-21       Impact factor: 4.241

6.  Study of oxaliplatin penetration into ovaries of patients treated with hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal metastases of colorectal and appendiceal origin using mass spectrometry imaging.

Authors:  Marion Larroque; Sandra Mounicou; Olivia Sgarbura; Carine Arnaudguilhem; Lucie Rebel; Cristina Leaha; Pierre-Arnaud Faye; Christine Enjalbal; François Quénet; Brice Bouyssiere; Sébastien Carrere
Journal:  Pleura Peritoneum       Date:  2021-03-24
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.